NTLA
Intellia Therapeutics, Inc. · Healthcare
VP and Chief Accounting Officer Michael P Dube sold $38K of Intellia Therapeutics, Inc.
Sold$38,248
$19.01Price
2,012Shares
−4%Stake
What NTLA did after the filing
- The stock from Fri, Oct 4 close, $17.99
- −22.3%
- S&P 500, same days
- +2.2%
Measured over 30 trading days, to the Nov 15 close.
Traded Wed, Oct 2. Filed Fri, Oct 4, 1:29 PM ET, during the session. Returns use the Oct 4 close and the Nov 15 close. Not investment advice.